DTi Diffusion Findings in Breast MRI Screening and Diagnostic
NCT03158441 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-04-23
Summary
Introduction The most common breast cancer originates within the breast milk ducts, and is called ductal carcinoma. After the stage where the cancer is found only within the ducts, it invades the breast tissue beyond the ducts, and becomes invasive cancer (Infiltrating Duct Carcinoma). Breast cancer located within the ducts is called intra ductal carcinoma in situ- DCIS. DCIS is the developing cancer and usually does not metastasize. Another type of breast cancer originates within the breast lobules and is call lobular carcinoma.
Recently at the Weizmann Institute, Prof. Hadassa Degani and her group developed and imaging technique using breast MRI. This technique allows to map the three-dimensional structure of the milk ducts in the breast. The method is based on measuring the random movement (Brownian motion) of water molecules (diffusion) in different directions in the breast tissue, collecting diffusion images by using magnetic field gradients in different directions, allowing imaging of Diffusion tensor Imaging -DTI. Movement of water molecules within a unified solution is usually random and uniform in all directions, but the internal structures in biological systems (such as cells, pipelines, fiber) restrict the movement of water in certain directions. The DTI method exploits this feature by measuring the diffusion in various directions, thus enabling calculating images of biological structures \[1\]. This method was proved to be effective in mapping the brain's white matter fibers and is used routinely in clinical tests used to monitor neurological injuries \[2-4\]. This method was used for milk ducts mapping within breast tissue at the Weizmann Institute. The system that was developed at the Weizmann Institute, showed that the movement of water molecules along the milk ducts is faster than their movement across the ducts and therefore it was possible using this method to map the breast ductal system. Also this method showed that it is possible to detect and diagnose malignant changes within breast and to distinguish them from normal tissue and benign tumors using DTI. Changes in cell density and arrangement causes changes in the directional diffusion coefficients and the differences between them \[5-9\] Research Plan Summary A prospective preliminary study to evaluate the correlation between the DTI analysis of breast MRI and the results of conventional contrast enhanced breast MRI.
The patients enrolled for the study will be women scheduled for breast MRI due to high risk screening or pretreatment evaluation. The patients will fill in a form regarding: age, hormonal status, risk factors, prior breast surgery or treatment (a form which is routinely filled out in our institution). They will then undergo a breast MRI scan, using the routine protocol in our institution. This will be directly followed by a DTI sequence, which takes about 10 minutes in addition to the regular examination. The DTI sequence is routinely used in other imaging institutions, as part of the breast MRI protocol.
The exams will be read on our regular work stations, and in addition will be analyzed by software developed at the Weizmann Institute. Both interpretations will then be compared to each other and to clinical and pathological data
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Breast MRI
comparison of DTI to dynamic MRI
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Ahuva Grubstein, MD · Tel Aviv University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2020-07-01
- Completion
- 2025-07-01
More Related Trials
-
Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography
NCT01593384 ·Status: WITHDRAWN
-
Diffusion Tensor Breast MRI (DTI)
NCT02812589 ·Status: COMPLETED ·Phase: NA
-
Breast MRI as a Preoperative Tool for DCIS
NCT00605982 ·Status: COMPLETED ·Phase: NA
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
NCT00804128 ·Status: COMPLETED
-
Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast Cancer
NCT04619186 ·Status: SUSPENDED
-
Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients
NCT02024074 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast Cancer
NCT03190083 ·Status: COMPLETED ·Phase: NA
-
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
NCT03148015 ·Status: COMPLETED
-
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
NCT01938157 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
NCT00208871 ·Status: COMPLETED ·Phase: NA
-
DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer
NCT02022579 ·Status: UNKNOWN ·Phase: NA
-
MRI to Detect Breast Tumors in Women
NCT00003302 ·Status: COMPLETED ·Phase: NA
-
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
NCT03703492 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)
NCT00890994 ·Status: COMPLETED
-
Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective Trial
NCT02818946 ·Status: TERMINATED ·Phase: NA
-
Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast Lesions
NCT02529384 ·Status: UNKNOWN
-
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346 ·Status: TERMINATED ·Phase: PHASE3
-
Molecular Imaging of Breast Cancer With Breast PET/CT
NCT00584753 ·Status: TERMINATED ·Phase: PHASE1
-
Quantitative Assessment of Diffusion Spectrum Imaging in Breast Cancer
NCT05159323 ·Status: UNKNOWN ·Phase: NA
-
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
NCT00003736 ·Status: COMPLETED ·Phase: NA
-
Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer
NCT04656639 ·Status: RECRUITING
-
Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation
NCT01684735 ·Status: COMPLETED
-
Molecular Breast Imaging: A Novel Technology for Detection of Malignant Breast Lesions
NCT01004666 ·Status: UNKNOWN
-
The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions
NCT06854887 ·Status: NOT_YET_RECRUITING